Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral

Sergey M Ivanov1,2, Olga A Tarasova1, Vladimir V Poroikov1

  • 1Department of Bioinformatics, Institute of Biomedical Chemistry, Moscow, Russia.

Frontiers in Immunology
|October 5, 2023
PubMed
Abstract

Insights

Developing new antiviral drugs is challenging. This study reveals common immune system disruptions across nine viral infections, identifying key receptors for potential new therapies against severe viral diseases.

Area of Science:

  • Immunology
  • Virology
  • Computational Biology

Background:

  • Developing direct antiviral drugs for emerging viruses like COVID-19 is difficult.
  • Pathogenesis-directed therapy is crucial for severe viral infections and associated conditions.
  • Viral infections often lead to significant immune system dysfunction.

Purpose of the Study:

  • To identify common mechanisms of immune dysfunction across nine different viral infections.
  • To find master regulators responsible for immune alterations in viral infections.
  • To explore novel therapeutic strategies targeting shared immune pathways.

Main Methods:

  • Analyzed transcriptome profiles from peripheral blood mononuclear cells (PBMC) of patients with nine viral infections.
  • Utilized a custom pipeline for data collection, processing, normalization, and analysis.
  • Employed network analysis to identify key receptors and signaling pathways involved in immune disruption.

Main Results:

  • All nine viral infections induced immune activation, exhaustion, disrupted cell proliferation, and increased apoptosis.
  • Identified common pathways and master regulators across diverse viral infections.
  • Discovered novel PBMC receptors (e.g., for insulin, prolactin) linked to virus-induced immune changes.

Conclusions:

  • Shared immune dysregulation mechanisms exist across various viral infections.
  • Specific PBMC receptors represent potential therapeutic targets for severe viral diseases.
  • Modulating identified receptors offers a promising strategy for treating viral infections and comorbidities.